Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Lenting

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
Journal of Thrombosis and Haemostasis : JTH|February 8, 2023
von Willebrand factor: from figurant to main character in the scene of inflammationPeter J Lenting, Alexis Texier, Caterina Casari
Current Vascular Pharmacology|August 3, 2013
Von Willebrand factor and thrombosis: risk factor, actor and pharmacological targetPeter J Lenting, Cécile V Denis, Nikolett Wohner
Blood|March 4, 2021
von Willebrand disease: what does the future hold?Cécile V Denis, Sophie Susen, Peter J Lenting
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2022
Towards novel treatment options in von Willebrand diseasePeter J Lenting, Claire Kizlik-Manson, Caterina Casari
Journal of Thrombosis and Haemostasis : JTH|January 21, 2022
TaSER: Combining forces to stop the clotCécile V Denis, Peter J Lenting, Denis Wahl
Blood|February 26, 2015
von Willebrand factor biosynthesis, secretion, and clearance: connecting the far endsPeter J Lenting, Olivier D Christophe, Cécile V Denis
Blood|October 19, 2017
Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?Peter J Lenting, Cécile V Denis, Olivier D Christophe
Blood|July 5, 2024
How unique structural adaptations support and coordinate the complex function of von Willebrand factorPeter J Lenting, Cécile V Denis, Olivier D Christophe
Therapeutic Advances in Hematology|January 30, 2026
Nine areas with outstanding challenges for hemophilia B researchJan Astermark, Cédric Hermans, Peter J Lenting, et al.
Mediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
Von Willebrand Factor Abnormalities Studied in the Mouse Model: What We Learned about VWF FunctionsCaterina Casari, Peter J Lenting, Olivier D Christophe, et al.
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Journal of Thrombosis and Haemostasis : JTH|February 8, 2023
von Willebrand factor: from figurant to main character in the scene of inflammationPeter J Lenting, Alexis Texier, Caterina Casari
Current Vascular Pharmacology|August 3, 2013
Von Willebrand factor and thrombosis: risk factor, actor and pharmacological targetPeter J Lenting, Cécile V Denis, Nikolett Wohner
Blood|March 4, 2021
von Willebrand disease: what does the future hold?Cécile V Denis, Sophie Susen, Peter J Lenting
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2022
Towards novel treatment options in von Willebrand diseasePeter J Lenting, Claire Kizlik-Manson, Caterina Casari
Journal of Thrombosis and Haemostasis : JTH|January 21, 2022
TaSER: Combining forces to stop the clotCécile V Denis, Peter J Lenting, Denis Wahl
Blood|February 26, 2015
von Willebrand factor biosynthesis, secretion, and clearance: connecting the far endsPeter J Lenting, Olivier D Christophe, Cécile V Denis
Blood|October 19, 2017
Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?Peter J Lenting, Cécile V Denis, Olivier D Christophe
Blood|July 5, 2024
How unique structural adaptations support and coordinate the complex function of von Willebrand factorPeter J Lenting, Cécile V Denis, Olivier D Christophe
Therapeutic Advances in Hematology|January 30, 2026
Nine areas with outstanding challenges for hemophilia B researchJan Astermark, Cédric Hermans, Peter J Lenting, et al.
Mediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
Von Willebrand Factor Abnormalities Studied in the Mouse Model: What We Learned about VWF FunctionsCaterina Casari, Peter J Lenting, Olivier D Christophe, et al.
Pageof 17